Amlodipine Besylate/Chlortalidone/Telmisartan

苯磺酸氨氯地平/氯噻酮/替米沙坦

Report date: 2026/04/20 20:01:59

Base Information

Drug NameAmlodipine Besylate/Chlortalidone/Telmisartan
Drug Alias NameAmlodipine Besilate/Chlortalidone/Telmisartan氯噻酮/替米沙坦/苯磺酸氨氯地平苯磺酸氨氯地平氯噻酮替米沙坦Telmisartan/Chlorthalidone/Amlodipine Besilate氯噻酮替米沙坦苯磺酸氨氯地平 +[10] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitorsVoltage-gated calcium channel blockers
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2026/01/15
Country/TerritorySouth Korea
CombinationsYes Amlodipine BesylateTelmisartanChlorthalidone
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesSk Chemicals Co Ltd
Inactive CompaniesYuhan Corp
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A